drugset / Trial / NCT03908944

Postoperative Pain and Headache After Craniotomy

NCT03908944

Phase 2 Withdrawn Steven Edelstein
RandomizedParallel-groupSingle-blindOther

Summary

The purpose of this study is to assess the outcomes of an anesthetic technique which is not synthetic opioid based, on postoperative pain modulation and development of post craniotomy headache against a cohort of patients where an opioid based standard anesthetic technique was used for craniotomy. The hypothesis that is tested is that the use of agents other than synthetic short acting opioids will reduce the amount of postoperative pain and the incidence of headache after surgery.

Timeline

Start
2019-01-02
Primary completion
2021-01-02
Completion
2022-01-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Methadone Other / unclassified 0.2 mg/kg Intravenous
Comparator Remifentanil Small molecule
Comparator Fentanyl Other / unclassified
Background Lidocaine Other / unclassified 2 mg/kg

Indications

No indication recorded.